Latest News for: parp activity

Edit

Metastatic Breast Cancer Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ...

GetNews 03 Apr 2025
The PARP inhibitor demonstrated clinical activity in a prior Phase 1 study in a number of solid tumors ... The molecule is also active in P-glycoprotein expressing cells, suggesting it may overcome some of the PARP inhibitor resistance.
  • 1
×